These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1599 related articles for article (PubMed ID: 15494875)

  • 1. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective evaluation of children with immune thrombocytopenic purpura and factors contributing to chronicity.
    Güngör T; Arman Bilir Ö; Koşan Çulha V; Güngör A; Kara A; Azık FM; Yaralı HN
    Pediatr Neonatol; 2019 Aug; 60(4):411-416. PubMed ID: 30470618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic thrombocytopenic purpura diagnosed during the second decade of life.
    Lowe EJ; Buchanan GR
    J Pediatr; 2002 Aug; 141(2):253-8. PubMed ID: 12183723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of immune thrombocytopenic purpura in children : current concepts.
    Shad AT; Gonzalez CE; Sandler SG
    Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
    Rodeghiero F
    Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute immune thrombocytopenic purpura.
    Tarantino MD; Goldsmith G
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic thrombocytopenic purpura: a 15-year natural history study at the Children's Hospital Rijeka, Croatia.
    Roganovic J; Letica-Crepulja M
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):662-4. PubMed ID: 16933251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood acute immune thrombocytopenic purpura: 20 years later.
    Blanchette VS; Carcao M
    Semin Thromb Hemost; 2003 Dec; 29(6):605-17. PubMed ID: 14719177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seventeen years of experience with chronic idiopathic thrombocytopenic purpura in childhood. Is therapy always better?
    Aronis S; Platokouki H; Mitsika A; Haidas S; Constantopoulos A
    Pediatr Hematol Oncol; 1994; 11(5):487-98. PubMed ID: 7826845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura.
    Erduran E; Aslan Y; Gedik Y; Orhan F
    Turk J Pediatr; 2003; 45(4):295-300. PubMed ID: 14768792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome.
    Medeiros D; Buchanan GR
    J Pediatr; 1998 Sep; 133(3):334-9. PubMed ID: 9738712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children.
    Freiberg A; Mauger D
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic immune thrombocytopenic purpura in children: a survey of the canadian experience.
    Belletrutti M; Ali K; Barnard D; Blanchette V; Chan A; David M; Luke B; Price V; Ritchie B; Wu J; ;
    J Pediatr Hematol Oncol; 2007 Feb; 29(2):95-100. PubMed ID: 17279005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune thrombocytopenic purpura in adults in the last 10 years: single-centre experience.
    Pavkovic M; Trpkovska-Terzieva S; Sotirova T; Latifi A; Cevreska L; Stojanovic A
    Prilozi; 2012; 33(1):121-33. PubMed ID: 22952099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
    Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura.
    Kumar M; Vik TA; Johnson CS; Southwood ME; Croop JM
    Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Idiopathic thrombocytopenic purpura in children].
    Gebauer E; Vijatov G
    Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of autoimmune thrombocytopenic purpura: a prospective study of 147 children from the regional network RHémaP].
    Le Meignen M; Mossler P; Mates M; Mathey C; Hass A; Monpoux F; Faverge B; Fortier G; Nguyen J; Belahbib L; Coache C; Chamoulli JM; Moulène E; Sirvent N; Michel G; Chambost H
    Arch Pediatr; 2008 Sep; 15(9):1398-406. PubMed ID: 18676127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment. Associazione Italiana di Ematologia e Oncologia Pediatrica.
    De Mattia D; Del Principe D; Del Vecchio GC; Jankovic M; Arrighini A; Giordano P; Menichelli A; Mori P; Zecca M; Pession A
    Haematologica; 2000 Apr; 85(4):420-4. PubMed ID: 10756369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 80.